Aptus Pharma
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Grey market premium
Unofficial and indicative — not a forecast
3 observations recorded — too few to plot a trend.
Day-wise premium · 3 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 30 Sept 2025 | ₹4 | +5.71% | ₹6,100 | ₹74 | ₹8,000 |
| 29 Sept 2025 | ₹4 | +5.71% | ₹6,100 | ₹74 | ₹8,000 |
| 28 Sept 2025 | ₹4 | +5.71% | ₹6,100 | ₹74 | ₹8,000 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- IPO date
- 23 Sept 2025 – 25 Sept 2025
- Listing date
- 30 Sept 2025
- Face value
- ₹10 per share
- Issue price
- ₹70 per share
- Lot size
- 2,000 shares
- Issue type
- Book Building issue
- Total issue size
- ₹13.02 Cr
- Market cap at offer price
- ₹48.02 Cr
- Promoter holding
- 100.00% → 72.89% pre-issue → post-issue
- ISIN
- INE15XJ01010
- Registrar
- Bigshare Services Pvt.Ltd.
- Lead managers
- Interactive Financial Services Ltd.
- Registered office
- Ashutosh Buildcon, Opp.Slok-2, Nr.Harikrupa Logistic Park, Aslali, Daskroi, Gujarat
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 5,28,000 | — | — |
| Market maker | 94,000 | — | — |
Application size
Minimum 2,000 shares per lot, in multiples, at ₹70
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 2,000 | ₹1,40,000 |
| S-HNI (min) | 2 | 4,000 | ₹2,80,000 |
| S-HNI (max) | 7 | 14,000 | ₹9,80,000 |
| B-HNI (min) | 8 | 16,000 | ₹11,20,000 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹70 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 6.20 | 4.52 |
| P/E (×) | 11.29 | 15.49 |
| Market cap | — | ₹48.02 Cr |
Key performance indicators
Latest reported period
- Return on net worth
- 44.50%
- ROCE
- 45.66%
- Debt / equity
- 1.49
- PAT margin
- 12.62%
- EBITDA margin
- 19.31%
- NAV per share
- ₹13.93
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.